Elective nodal radiotherapy in prostate cancer-Reference-Cited by-同舟云学术

Elective nodal radiotherapy in prostate cancer

Published:2021-08 Issue:8 Volume:22 Page:e348-e357
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

De Meerleer Gert,Berghen Charlien,Briganti Alberto,Vulsteke Christof,Murray Julia,Joniau Steven,Leliveld Anne M,Cozzarini Cesare,Decaestecker Karel,Rans Kato,Fonteyne Valerie,De Hertogh Olivier,Bossi Alberto

Publisher

Elsevier BV

Subject

Oncology

Reference73 articles.

1. Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial;Roach;Lancet Oncol,2018

2. The role of elective pelvic radiotherapy in clinically node-negative prostate cancer: a systematic review;Dirix;Radiother Oncol,2014

3. Toxicity and patient-reported outcomes of a phase 2 randomized trial of prostate and pelvic lymph node versus prostate only radiotherapy in advanced localised prostate cancer (PIVOTAL);Dearnaley;Int J Radiat Oncol Biol Phys,2019

4. New approaches for effective and safe pelvic radiotherapy in high-risk prostate cancer;Tharmalingam;Nat Rev Urol,2019

5. Definition of lymph node areas for radiotherapy of prostate cancer: a critical literature review by the French Genito-Urinary Group and the French Association of Urology (GETUG-AFU);Sargos;Cancer Treat Rev,2015

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A retrospective evaluation of inter-fraction motion in prostate cancer patients with involved nodes receiving prostate and pelvic ± para-aortic nodal irradiation;Journal of Medical Imaging and Radiation Sciences;2024-12

2. Pushing the Borders: One at a Time. Reply to C. Onal, A. Elmaliy, P. Hurmuz's Letter to Editor Re: Patterns of Failure After Prostate-Only Radiotherapy in High-Risk Prostate Cancer: Implications for Refining Pelvic Nodal Contouring Guidelines in Regard to Singh et al.;Clinical Oncology;2024-09

3. Volumetric Modulated Arc Therapy for High-Risk and Very High-Risk Locoregional Prostate Cancer in the Modern Era: Real-World Experience from an Asian Cohort;Cancers;2024-08-25

4. Reply: Considerations Surrounding the Sentinel Lymph Node in Prostate Cancer and Unanswered Questions;Journal of Nuclear Medicine;2024-07-25

5. Patterns of Failure After Prostate-Only Radiotherapy in High-Risk Prostate Cancer: Implications for Refining Pelvic Nodal Contouring Guidelines;Clinical Oncology;2024-07